Objective To examine trade-offs between cognitive outcome and overweight/obesity in preterm-born infants at school age and young adulthood in relation to weight gain and linear growth during infancy.
gain in BMI and linear growth from term to age 18 months with (1) overweight or obesity and (2) IQ <85 at age 8 years and 18 years in a cohort of children born preterm and with low birth weight. We hypothesized that linear growth, but not BMI gain, would positively impact IQ, whereas greater BMI gain would lead to greater overweight and obesity.
Methods
This study was an observational analysis of participants in the Infant Health and Development Program (IHDP), an 8-center longitudinal study of infants born preterm (#37 completed weeks gestation) and with low birth weight (#2500 g). In 1984 and 1985, the IHDP recruited infants to participate in a randomized trial of an early child development intervention for which the primary outcomes were cognitive development, behavior, and health status. Details of recruitment and follow-up and study results have been reported through age 18 years. [16] [17] [18] [19] Institutional Review Boards from all participating centers granted approval, and the infants' caregivers gave written informed consent.
For this analysis, out of the original 1060 IHDP participants, we included the 945 infants with data for IQ or BMI at age 8 or 18 years and 2 consecutive infant BMI measurements (term and 4 months, 4 and 12 months, or 12 and 18 months). In total, 941 participants were included in the age 8 analyses and 645 in the age 18 analyses. Details of participant flow are shown in Figure 1 (available at www.jpeds.com).
IHDP study staff weighed and measured participants at term and at age 4, 12, and 18 months corrected for prematurity (ie, chronologic age in days minus the number of days of birth before 40 weeks) using a calibrated infant balance scale and recumbent length board. 20 At age 8 years, study staff weighed children and measured them with a Ross stadiometer. At age 18 years, participants reported their own height and weight in a structured interview. To measure general intelligence, trained assessors administered the Weschler Intelligence Scale for Children-III at age 8 and the Weschler Abbreviated Scale of Intelligence at age 18.
Study staff collected data from the neonatal and maternal medical records and through interviews and questionnaires regarding parental and child demographic, socioeconomic, and health information. Maternal obesity was recorded if the mother reported her prepregnancy weight as >200 pounds. Gestational age was estimated using a modified Ballard assessment. 21 Maternal intelligence was measured using the Peabody Picture Vocabulary Test-Revised when the child was 18 months old.
For statistical analysis, all infant measurements were converted to z-scores based on World Health Organization growth standards, 22 which were designed to reflect optimal growth in infancy. Primary predictors were BMI gain and linear growth from term to 4 months, from 4 to 12 months, and from 12 to 18 months corrected for prematurity, defined as the z-score change between time points.
All age 8 years and 18 years, measurements were converted to percentiles based on Centers for Disease Control and Prevention growth charts. 23 Primary outcomes were weight status (underweight, overweight/obesity) and low IQ. Underweight was defined as BMI <5th percentile at age 8 and BMI <18.5 kg/m 2 at age 18; overweight/obesity was defined as BMI $85th percentile at age 8 and BMI $25 kg/m 2 at age 18. Short stature, defined as height <2.5th percentile was also examined. Low IQ was defined as Weschler Intelligence Scale for Children-III or Weschler Abbreviated Scale of Intelligence score <85, which is 1 SD below the population mean of 100.
Using multinomial logistic regression, we estimated the odds of underweight vs normal weight, overweight/obesity vs normal weight, and in separate models, short stature vs non-short stature and low IQ vs IQ $85, with 95% CIs, adjusting for child age, sex, and gestational age; and maternal age, education, smoking in pregnancy; and annual household income. As in a previous study, 14 we also adjusted the 4-to 12-month growth analyses for term to 4-month growth and size at 4 months in the same measurement. Similarly, we adjusted the 12-to 18-month growth analyses for term to 4 months and 4-to 12-month growth, and size at 12 months. We adjusted all analyses for the IHDP study groups (intervention vs control) and adjusted the cognitive analyses for maternal IQ.
To examine possible confounding by neonatal complications, we repeated the same analyses after excluding participants with 5-minute Apgar score <5, bronchopulmonary dysplasia, necrotizing enterocolitis, or grade 3 or 4 intraventricular hemorrhage, and repeated the same analyses. To examine potential effect modification by fetal growth status, we performed analyses stratified by small for gestational age (SGA), defined as birth weight <10th percentile for gestational age based on a contemporary national reference, 24 vs non-SGA. Only 4 participants were large for gestational age (>90th percentile), and we included them in the non-SGA group. All analyses were performed using SAS version 9.1 (SAS Institute, Cary, North Carolina). Table I (available at www.jpeds.com). The mean gestational age was 33 AE 2.6 weeks, and mean birth weight was 1800 AE 455 g. Slightly over 33% of the participants were SGA, and almost 20% had a neonatal complication. Figure 2 shows participants' BMI and length z-scores at term and age 4, 12, and 18 months. In our sample, BMI was higher than that of the reference population at term, but was lower by age 4 months. BMI was similar to that of the reference population at 12 months, and was slightly higher at 18 months. Length was below that of the reference population at term, was even lower at 4 months, increased somewhat by 12 months, but remained below that of the reference population through age 18 months. with somewhat lower odds of IQ <85 (OR, 0.81; 95% CI, 0.68-0.96). Associations with outcomes at age 18 years were similar in magnitude and direction. Linear growth from term to 4 months and from 4 to 12 months and BMI gain from 4 to 12 months were associated with lower odds of short stature at age 8, but not at 18.
Results

Participant characteristics are summarized in
After excluding infants with neonatal complications, associations of infant BMI gain and linear growth with age 8 and 18 outcomes were similar to the full cohort in magnitude and direction, although 95% CIs were somewhat wider. Associations were also similar for SGA and non-SGA participants, although the 95% CIs were wide as well (data not shown).
Discussion
In this study, we found that more rapid BMI gain and linear growth in infancy were associated with better cognition, but also with a greater risk of overweight/obesity at age 8 years, with similar effects seen at age 18 years. These findings suggest important trade-offs to consider with respect to optimal growth targets for preterm, low birth weight children after NICU discharge.
This study extends previous work linking early rapid weight gain with later obesity and cognition in 2 ways. First, most previous researchers have examined full-term populations, whereas we studied a preterm, low birth weight cohort. We found some similarities to the studies of full-term children, but also important differences. Consistent with studies of full-term children, 9,10 our results suggest that preterm infants are also vulnerable to the obesogenic effects of early rapid weight gain out of proportion to linear growth. This finding is notable in the context of epidemic child obesity, 25 with a similar prevalence of obesity in preterm and full-term children. 13, 26 In terms of cognition, however, preterm infants appear to be different from their full-term counterparts. Other studies, including one by our group 27 and a subsequent meta-analysis, 28 found that in healthy, full-term populations, rapid weight gain after birth was not associated with better cognition later in life, although few studies separated weight gain from linear growth. In contrast, in our preterm, low birth weight cohort, we found that more rapid linear growth in the months after term-developmentally equivalent to the months after a full term birth-may be of substantial benefit to later cognition. It is possible that for the preterm, low birth weight infant, the months after term represent a sensitive period that may be particularly important for neurodevelopment after a period of prenatal 29 and/or postnatal 2,3 growth restraint. A second way in which our study extends previous work is in differentiating linear growth from BMI gain after NICU discharge. In our study, even though early (term to 4 months) linear growth was associated with substantially lower odds of IQ <85 at 8 and 18 years, BMI gain during the same time period did not appear to benefit cognition, but was associated with higher odds of overweight/obesity. These findings are consistent with a previous study of preterm infants born at <33 weeks' gestation, which found an 14 Thus, even though early linear growth appears to be important for later cognition, our results suggest that excess early weight gain out of proportion to linear growth may contribute to later obesity, without cognitive benefits.
In our study, early (term to 4 months) linear growth appeared to benefit later cognition but, notably, was also associated with modestly higher odds of overweight/obesity. This finding raises the possibility that supporting optimal brain growth may come at a cost with respect to later cardiometabolic health. A similar trade-off was apparent with greater BMI gain from 4 to 12 months, which was associated with higher odds of overweight/obesity, but also with lower odds of IQ <85 at 8 years.
Defining optimal linear growth and BMI gain will require balancing the magnitude of effects on cardiometabolic health and cognition, as well as the value that clinicians and families place on the different outcomes. In addition to obesity and cognition, an important consideration with respect to early linear growth is its impact on adult height. In our study, more rapid linear growth in infancy appeared to be protective against short stature at age 8 years but not at age 18 years, suggesting that additional catch-up in linear growth occurred after age 8. Other relevant outcomes to consider include risk for rehospitalization, which may be greater in low birth weight children with slow weight gain, 30, 31 and asthma, which in one study was more prevalent in low birth weight children with high BMI vs those with low BMI during adolescence. 32 The children in our study population had a higher BMI and were shorter at term compared with the World Health Organization reference population of full-term children at birth. This finding is consistent with previous studies that directly measured body composition at term using either air displacement plethysmography 33, 34 or dual-energy x-ray absorptiometry 35 and found greater fat mass and lower fat-free mass in preterm children compared with full-term children. This difference may reflect excess nonprotein energy stored as fat in growing preterm infants. 36 A previous study that followed children after NICU discharge by age 3-6 months reported similar fat mass and fat-free mass in preterm and full-term children, 33 whereas in our cohort, both BMI and length were substantially below the reference population at 4 months. This difference may reflect the fact that anthropometric measurements only partially account for differences in direct measures of body composition. In addition, our cohort was born in the 1980s, when nutritional practices were different; for example, nutrient enriched postdischarge formulas were not in routine use at that time. Specific determinants of early fat accumulation and lean body mass growth, such as composition and fortification of formula and expressed milk, 37 energy expenditure, 38 and oral-motor feeding skills, 39 represent potential targets for intervention during this developmentally sensitive period.
Strengths of this study include a multicenter cohort with availability of detailed growth data at several time points after term, and later IQ and BMI measures in the same cohort. IQ and BMI measured at age 8 and 18 years are strongly correlated with adult outcomes. 40, 41 A limitation of the study is the reliance on self-reported weight and height measures at age 18 years. Although highly correlated with direct measures, 42 self-reported weight and height may underestimate the prevalence of overweight and obesity. 43 We were reassured that in this study, exposure-outcome relationships were similar to those found using direct measurements at Estimates adjusted for child age, sex, and gestational age; maternal age, education, and smoking during pregnancy; and annual household income. *Based on percentile cutpoints at age 8 years and BMI cutpoints at age 18 years. †Height <2.5th percentile for age and sex. zBased on World Health Organization growth standards. age 8. We controlled for a number of relevant covariates, but as in any observational study, there may be residual confounding by unmeasured factors. In particular, both slow early weight gain and poor cognitive outcomes could occur as a result of neonatal brain injury or other complications of preterm birth, although excluding children with such complications did not materially change our results. Finally, the IHDP included a large proportion of infants from poor households and mothers of low educational status and of minority race and ethnicity, possibly limiting the generalizability of our findings to more affluent, educated, and nonminority populations.
In conclusion, we found in a cohort of preterm, low birth weight infants born in the 1980s that early linear growth after term was associated with better cognitive outcome, but also with an elevated risk for overweight/obesity later in life. Excess weight gain out of proportion to linear growth from term through age 18 months was associated with later overweight/obesity, with less evidence of a substantial cognitive benefit. These trade-offs represent important considerations for pediatricians and other clinicians who monitor growth and provide nutritional care for preterm infants. n T he XXXXY syndrome, which had recently been defined by karyotype, was considered quite rare (frequency unknown at this time). The authors described a 17-month-old boy and compared and contrasted his findings with those of 8 other patients previously reported. As is quite common in the "new" description of a syndrome, virtually all of the subjects had almost all of the findings. Those signs and symptoms striking in this boy and the others reported included: severe developmental delay, hypoplastic genitalia, and multiple skeletal anomalies, especially radio-ulnar synostoses. Some of the features were consistent with Down syndrome and the authors distinguished between the two syndromes noting some similarities in the facies.
Fast forward 50 years-the clinical variability and detailed neurodevelopmental findings were presented for a group of 20 children seen in a single clinic. 1 Although the general findings remain the same-similar facial appearance, radio-ulnar synostosis, and developmental delay, there is a much wider spectrum of findings given the larger patient series but more importantly in this series, a full evaluation by a diverse pediatric-oriented team. Additional findings are severe speech delays (100%), synophrys (93%), but microphallus in only 20%. The neurocognitive signature notes greater strengths for non-verbal skills with more intact receptive vocabulary and comprehension skills. The severity of language-based learning deficits is moderate to severe and affects the ability of these boys to develop social interactions and results in behavioral manifestations of frustration and oppositional behavior. Taken together with additional orthopedic manifestations, for example pes planus, borderline growth deficiency, and generalized but variable hypotonia, the spectrum of presentation and manifestations of this chromosomal syndrome have broadened. 
